Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
More News related to ACOR
- Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
- Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Acorda Therapeutic (ACOR) volatility at 55 into extension of PDUFA
- Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
- Acorda Therapeutics Reports Third Quarter 2009 Financial Results
More News related to Earnings
- Sprint Nextel (S) Completes Tender Offer for iPCS, Inc. (IPCS)
- Ford (F) and Geely Reportedly Clear Hurdle On Possible Volvo Deal
- Starent Networks (STAR) To Settle Shareholder Class Action Suit In Connection With Proposed Merger with Cisco (CSCO)
- Hurray! Holding (HRAY) To Acquire Ku6 in All Stock Transaction
Acorda Therapeutics (NASDAQ: ACOR) reports Q3 loss of $0.51, 8 cents better than the analyst estimate of ($0.59). Revenue for the quarter was $15.21 million, which compares to the estimate of $14.22 million.
Related Categories
EarningsStocks Mentioned
-0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
